Myovant Sciences Other Current Liabilities

Myovant Sciences (MYOV) currently reports a other current liabilities of $110M as of December 2022. That compares with $99M in the prior-year period — up 14.4% year over year. Use the charts on this page to explore Myovant Sciences's other current liabilities history and peer comparisons.

Myovant Sciences's other current liabilities increased from $99M to $110M — a 14.4% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Myovant Sciences reported $110M in other current liabilities as of December 2022. That compares with $99M in the prior-year period — up 14.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Myovant Sciences, and consider following MYOV for alerts when major investors trade the stock.

Myovant Sciences is classified in the Healthcare sector. On other current liabilities, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MYOV with unrelated industries.